当前位置： SCI文献检索 > Archives of Osteoporosis期刊下所有文献 > Cost-benefit analysis of calcium and vitamin D supplements.

Cost-benefit analysis of calcium and vitamin D supplements.

Abstract：

:If all adults with osteoporosis in the European Union (EU) and United States (US) used calcium and vitamin D supplements, it could prevent more than 500,000 fractures/year in the EU and more than 300,000/year in the US and save approximately €5.7 billion and US $3.3 billion annually. PURPOSE:Evaluate the cost-effectiveness of calcium/vitamin D supplementation for preventing osteoporotic fractures. METHODS:A cost-benefit analysis tool was used to estimate the net cost savings from reduced fracture-related hospital expenses if adults with osteoporosis in the EU and US used calcium/vitamin D supplements. A 14% relative risk reduction of fracture with calcium/vitamin D supplementation from a recent systematic review and meta-analysis of randomized, controlled trials was used as the basis for the benefit estimate. Other model inputs were informed by epidemiologic, clinical, and cost data (2016-2017) obtained via the medical literature or public databases. Analyses estimated the total number of avoided fractures and associated cost savings with supplement use. Net cost benefit was calculated by subtracting the supplements' market costs from those savings. RESULTS:The > 30 million persons in the EU and nearly 11 million in US with osteoporosis experience about 3.9 million and 2.3 million fractures/year and have annual hospital costs exceeding €50 billion and $28 billion. If all persons with osteoporosis used calcium and vitamin D supplements, there would be an estimated 544,687 fewer fractures/year in the EU and 323,566 fewer in the US, saving over €6.9 billion and $3.9 billion; the net cost benefit would be €5,710,277,330 and $3,312,236,252, respectively. CONCLUSIONS:Calcium and vitamin D supplements are highly cost-effective, and expanded use could considerably reduce fractures and related costs. Although these analyses included individuals aged ≥ 50 years, the observed effects are likely driven by benefits observed in those aged ≥ 65 years.

journal_name

Arch Osteoporos

journal_title

Archives of osteoporosis

authors

Weaver CM,Bischoff-Ferrari HA,Shanahan CJ

doi

10.1007/s11657-019-0589-y

subject

Has Abstract

pub_date

2019-04-30 00:00:00

pages

issue

eissn

1862-3522

issn

1862-3514

pii

10.1007/s11657-019-0589-y

journal_volume

pub_type

杂志文章

在线工具

Cost-benefit analysis of calcium and vitamin D supplements.